title: Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
abstract: Kwonjune Seung and colleagues describe the Eugene Bell Foundation's experience of treating MDR-TB in North Korea.
authors.affiliation: Eugene Bell Foundation, New Freedom, Pennsylvania, United States of America.|Partners In Health, Boston, Massachusetts, United States of America.|Brigham and Women's Hospital, Division of Global Health Equity, Boston, Massachusetts, United States of America.|Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Kwonjune J
authors.initials: KJ
authors.lastname: Seung
authors.affiliation: Partners In Health, Boston, Massachusetts, United States of America.|Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Molly
authors.initials: M
authors.lastname: Franke
authors.affiliation: Eugene Bell Foundation, New Freedom, Pennsylvania, United States of America.
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Linton
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D057191:Capacity Building; D056911:Democratic People's Republic of Korea / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents